Adenovirus

Coronavirus

Human Metapneumovirus

Influenza A

Influenza B

Parainfluenza 1, 2, 3, and 4

Respiratory Syncytial Virus

Bordatella pertussis

Bordatella parapertussis

Chlamydia pneumoniae

Mycoplasma pneumoniae

SARS-CoV-2

Rhinovirus/Enterovirus

VTM (viral transport media)

Remel M4RT UTM Sample Collection Kit

Xpert UTM Nasopharyngeal Specimen Collection Kit

BD Universal Viral Transport System Kit

Trinity Biotech Bartels FlexTans Transport Medium

Handle UTM Media Collection Kit

0.6mL

*This volume allows for 1 (one) repeat test if necessary

Room temperature: 4 hours

Refrigerated: 3 days

Frozen: 30 days

Non-nasopharyngeal specimen

Large swab 

E-swab collection devices cannot be used for this test

Viral and bacterial nucleic acids may persist in vivo independent of organism viability.

A negative result does not exclude the possibility of viral or bacterial infection. Negative test results may occur from the presence of sequence variants in the region targeted by the assay, the presence of inhibitors, technical error, sample mix-up or and infection caused by and organism not detected by the panel.  Test results may also be affected by concurrent antiviral/antibacterial therapy levels of organisms in the specimen that are below the limit of detection for the test. Negative results should not be used as the sole basis for diagnosis, treatment, or other management decisions. Negative results in the setting of a respiratory illness may be due to infection with pathogens that are not detected by this test or lower respiratory  tract infection that is not detected by a nasopharyngeal swab specimen.

Positive and negative predictive values are highly dependent on prevalence.  False negative test results are more likely during peak activity when prevalence of disease is high. False positive test results are more likely during periods when prevalence is moderate to low.

Due to the genetic similarity between Human Rhinovirus and Enterovirus, the Respiratory Pathogen Panel cannot reliably differentiate them.

Nucleic acid test by PCR

Respiratory pathogens cause acute local and systemic disease of varying severity, with the most severe cases occurring in children, the elderly and immunocompromised individuals. Due to the similarity of diseases caused by many viruses and bacteria, diagnosis based on clinical symptoms alone is difficult. Identification of potential causative agents provides data to aid the physicians in determining appropriate patient treatment.

The detection and identification of specific viral and bacterial nucleic acids from individuals exhibiting signs and/or symptoms of a respiratory infection aids in the diagnosis of respiratory infection if used in conjunction with other clinical and epidemiological information. The results of this test should not be used as the sole basis for diagnosis, treatment, or other patient management decisions.